|
|
|
Clinical
Informatics |
| |
GlucoDYNAMIX™ Diabetes
Interventions; Over 125,000 Served
Diabetech®'s GlucoDYNAMIX
November 29, 2006
Automated Diabetes Technology Delivers Over 125,000
Interventions With Demonstrated Improvements in Clinical
Outcomes & Cost Savings
Dallas, TX -- Diabetech®'s GlucoDYNAMIX diabetes intervention
system raises the bar for interventional healthcare.
GlucoDYNAMIX intelligent interventions have evolved over the
past 5 years based on experience from over a dozen clinical
trials with input from leading physicians, endocrinologists,
behavioral psychologists, medical informatics researchers,
people with diabetes and their extended care teams. |
| |
|
|
| |
"GlucoDYNAMIX
represents an entirely new category of healthcare information
technology," says Kevin McMahon, President & CEO of Diabetech.
"Looking across the board at pharma trials, clinical management
and patient self-management, virtually everything out there is
just now talking about moving to web-based data distribution
versus the cumbersome cabled PC application. The key to enabling
desperately needed improved outcomes isn't merely changing the
location of stored patient data from the medical device to the
PC or on the Web. Rather, it's about empowering patients, their
social networks and simultaneously increasing the caring
capacity and effectiveness of an overworked and inefficient
healthcare system.
Interventions are delivered using any number of software
interfaces including web, email, imaging, text messaging,
ambient displays, telephone and more. More importantly, only
Diabetech has the clinical trials experience across all
different types of patients to understand not only when and how
but also when not to intervene. The result is a 98% satisfaction
rating from our trial participants including patients,
caregivers and members of the medical team.
The platform is based on a sophisticated real-time wireline &
wireless gateway. In this way, data from multiple medical
devices is collected on the fly, as the data is created. In
turn, the remote system analyzes each data point as well as
trends in the patient record and determines the best time to
intervene.
Diabetech is presently developing its 510(k) application for the
GlucoDYNAMIX software system and plans to submit to the FDA in
Q1 2007. We anticipate receiving marketing clearance around the
middle of next year opening the doors to large-scale commercial
expansion of several recent clinical trials. Based on the data
collected so far, we plan to seek indications that correlate to
the significant drops witnessed in trial participant's average
blood glucose levels (as measured by the A1c test), decreased
frequency of severe hypoglycemia and minimized extended
excursions of hyperglycemia.
This service offering is compliant with applicable federal and
state regulations including HIPAA, which govern the privacy and
security of human subjects research. For more information please
call 877.My.Gluco or send email to info @ diabetech.net.
About Diabetech
Diabetech, with its healthcordia™ and diabetes house call™
programs, leads the world with more interventions served than
any other diabetes program provider. A Dallas, Texas based
manufacturer of wireless medical devices, diabetes supplies and
service provider infrastructure, we push the limits of clinical
informatics in the delivery of real-world diabetes care. For
more information on the company and to participate in our
version of proactive care, please visit www.diabetech.net
Diabetech and GlucoMON are registered trademarks of Diabetech,
LP. Healthcordia, Diabetes House Call and GlucoDYNAMIX are
trademarks of Diabetech, LP. All other trademarks are the
property of their registered owners. |
| |
|
|
